Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alan Stone & Company is a boutique investment banking and investor relations firm that specializes in providing strategic advisory services to emerging growth companies, with a significant focus on the life sciences, healthcare, and technology sectors. The firm offers a range of services including corporate finance, mergers and acquisitions advisory, and comprehensive investor relations programs designed to enhance shareholder value and market visibility. By leveraging deep industry expertise and an extensive network of institutional investors, Alan Stone & Company assists micro-cap and small-cap companies in navigating capital markets and executing growth strategies. The firm is also well-known for its 'WallStreet Research' publication, which provides independent analytical coverage of undervalued equities in the healthcare and biotech space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alan Stone & Company.